Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 14
27
Diseases
170
Unique genes
0.214
Avg. similarity score
Pituitary short stature
Most-connected disease (22 links)
Disease
Searched: Hypogonadotropic hypogonadism 10 with or without anosmia
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hypogonadotropic hypogonadism 10 with or without anosmia
Pituitary short stature
Kallmann syndrome
Sheehan syndrome
Growth hormone deficiency
Panhypopituitarism
Pituitary stalk interruption syndrome
Hypogonadism
Hypopituitarism
Hypogonadotropic hypogonadism
Pituitary dwarfism
Congenital hypogonadotrophic hypogonadism
Hypogonadotropic hypogonadism 15 with or without anosmia
Hypogonadotropic hypogonadism 17 with or without anosmia
Hypogonadotropic hypogonadism 19 with or without anosmia
Hypogonadotropic hypogonadism 20 with or without anosmia
Hypogonadotropic hypogonadism 21 with or without anosmia
Hypogonadotropic hypogonadism 22 with or without anosmia
Hypogonadotropic hypogonadism 9 with or without anosmia
Hypogonadotropic hypogonadism 13 with or without anosmia
Hypogonadotropic hypogonadism 18 with or without anosmia
Hypogonadotropic hypogonadism 4 with or without anosmia
Hypogonadotropic hypogonadism 3 with or without anosmia
Amyotrophic lateral sclerosis type 15
Brody myopathy
Cohen syndrome
Medulloblastoma predisposition
Member diseases (most connected first ‐ the cluster's core)
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| IL17RD | 10 / 27 | Growth hormone deficiency, Hypogonadism, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 18 with or without anosmia and 6 more |
| KISS1R | 10 / 27 | Growth hormone deficiency, Hypogonadism, Hypogonadotropic hypogonadism, Hypopituitarism and 6 more |
| NSMF | 10 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 9 with or without anosmia, Hypopituitarism and 6 more |
| PROKR2 | 10 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 3 with or without anosmia, Hypopituitarism and 6 more |
| TAC3 | 10 / 27 | Growth hormone deficiency, Hypogonadism, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 10 with or without anosmia and 6 more |
| CHD7 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 5 more |
| DUSP6 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 19 with or without anosmia, Hypopituitarism and 5 more |
| FEZF1 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 22 with or without anosmia, Hypopituitarism and 5 more |
| FGF17 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 20 with or without anosmia, Hypopituitarism and 5 more |
| FLRT3 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 21 with or without anosmia, Hypopituitarism and 5 more |
| GNRH1 | 9 / 27 | Growth hormone deficiency, Hypogonadism, Hypogonadotropic hypogonadism, Hypopituitarism and 5 more |
| GNRHR | 9 / 27 | Growth hormone deficiency, Hypogonadism, Hypogonadotropic hypogonadism, Hypopituitarism and 5 more |
| HS6ST1 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 15 with or without anosmia, Hypopituitarism and 5 more |
| KISS1 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 13 with or without anosmia, Hypopituitarism and 5 more |
| NDNF | 9 / 27 | Congenital hypogonadotrophic hypogonadism, Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism and 5 more |
| PROK2 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 4 with or without anosmia, Hypopituitarism and 5 more |
| SPRY4 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism 17 with or without anosmia, Hypopituitarism and 5 more |
| TACR3 | 9 / 27 | Growth hormone deficiency, Hypogonadism, Hypogonadotropic hypogonadism, Hypopituitarism and 5 more |
| WDR11 | 9 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 5 more |
| ANOS1 | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| AXL | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| BTK | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| CCDC141 | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| DNA2 | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| FGF8 | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| GH1 | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| GHRHR | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| NHLH2 | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| SEMA3A | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| SEMA3E | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| SOX10 | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| SRA1 | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| TCF12 | 8 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 4 more |
| FGFR1 | 7 / 27 | Growth hormone deficiency, Hypogonadotropic hypogonadism, Hypopituitarism, Kallmann syndrome and 3 more |
| PROP1 | 4 / 27 | Hypogonadism, Hypopituitarism, Panhypopituitarism, Pituitary dwarfism |
| HESX1 | 3 / 27 | Kallmann syndrome, Panhypopituitarism, Pituitary stalk interruption syndrome |
| LHX4 | 3 / 27 | Hypopituitarism, Panhypopituitarism, Pituitary stalk interruption syndrome |
| ATP2A1 | 2 / 27 | Brody myopathy, Hypogonadism |
| CYP17A1 | 2 / 27 | Hypogonadism, Hypopituitarism |
| CYP19A1 | 2 / 27 | Hypogonadism, Hypopituitarism |
| FSHB | 2 / 27 | Hypogonadism, Hypogonadotropic hypogonadism |
| GPR161 | 2 / 27 | Medulloblastoma predisposition, Pituitary stalk interruption syndrome |
| LHB | 2 / 27 | Hypogonadism, Hypogonadotropic hypogonadism |
| PNPLA6 | 2 / 27 | Hypogonadotropic hypogonadism, Kallmann syndrome |
| POU1F1 | 2 / 27 | Panhypopituitarism, Pituitary dwarfism |
| PRL | 2 / 27 | Hypogonadism, Hypopituitarism |
| RNPC3 | 2 / 27 | Growth hormone deficiency, Pituitary dwarfism |
| ROBO1 | 2 / 27 | Hypopituitarism, Pituitary stalk interruption syndrome |
| SOX11 | 2 / 27 | Hypogonadotropic hypogonadism, Pituitary stalk interruption syndrome |
| UBQLN2 | 2 / 27 | Amyotrophic lateral sclerosis type 15, Hypogonadism |
| VPS13B | 2 / 27 | Cohen syndrome, Pituitary stalk interruption syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Hormone ligand-binding receptors | Reactome | 5 / 12 | 29.4× | 3.92e-7 | 1.84e-5 ✓ sig. |
| Hormone signaling | KEGG | 13 / 219 | 4.2× | 1.38e-5 | 3.80e-4 ✓ sig. |
| FGFR1c ligand binding and activation | Reactome | 4 / 12 | 23.5× | 1.76e-5 | 4.68e-4 ✓ sig. |
| Neuroactive ligand-receptor interaction | KEGG | 16 / 370 | 3.1× | 7.11e-5 | 1.44e-3 ✓ sig. |
| FGFR3b ligand binding and activation | Reactome | 3 / 7 | 30.3× | 9.35e-5 | 1.80e-3 ✓ sig. |
| Downstream signaling of activated FGFR1 | Reactome | 4 / 18 | 15.7× | 1.02e-4 | 1.92e-3 ✓ sig. |
| Steroid hormone biosynthesis | KEGG | 6 / 63 | 6.7× | 2.57e-4 | 3.99e-3 ✓ sig. |
| Axon guidance | KEGG | 10 / 183 | 3.9× | 2.73e-4 | 4.19e-3 ✓ sig. |
| Androgen biosynthesis | Reactome | 3 / 11 | 19.3× | 4.23e-4 | 5.87e-3 ✓ sig. |
| Signaling by activated point mutants of FGFR1 | Reactome | 3 / 11 | 19.3× | 4.23e-4 | 5.87e-3 ✓ sig. |
| Negative regulation of FGFR1 signaling | Reactome | 4 / 26 | 10.9× | 4.54e-4 | 6.20e-3 ✓ sig. |
| Glycoprotein hormones | Reactome | 3 / 12 | 17.7× | 5.58e-4 | 7.28e-3 ✓ sig. |
| Prolactin receptor signaling | Reactome | 3 / 12 | 17.7× | 5.58e-4 | 7.28e-3 ✓ sig. |
| Signaling by activated point mutants of FGFR3 | Reactome | 3 / 12 | 17.7× | 5.58e-4 | 7.28e-3 ✓ sig. |
| FGFR3 mutant receptor activation | Reactome | 3 / 12 | 17.7× | 5.58e-4 | 7.28e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| pituitary gland development | GO:0021983 | 8 / 30 | 29.3× | 1.96e-10 | 5.59e-8 ✓ sig. |
| axon guidance | GO:0007411 | 15 / 192 | 8.6× | 2.50e-10 | 6.95e-8 ✓ sig. |
| mammary gland development | GO:0030879 | 6 / 37 | 17.8× | 9.55e-7 | 8.27e-5 ✓ sig. |
| negative chemotaxis | GO:0050919 | 6 / 40 | 16.5× | 1.54e-6 | 1.23e-4 ✓ sig. |
| motor neuron axon guidance | GO:0008045 | 5 / 24 | 22.9× | 2.17e-6 | 1.62e-4 ✓ sig. |
| hormone metabolic process | GO:0042445 | 5 / 25 | 22.0× | 2.69e-6 | 1.92e-4 ✓ sig. |
| somatotropin secreting cell differentiation | GO:0060126 | 3 / 4 | 82.4× | 2.94e-6 | 2.06e-4 ✓ sig. |
| female gonad development | GO:0008585 | 5 / 27 | 20.4× | 4.03e-6 | 2.67e-4 ✓ sig. |
| forebrain development | GO:0030900 | 7 / 76 | 10.1× | 5.88e-6 | 3.60e-4 ✓ sig. |
| positive regulation of MAPK cascade | GO:0043410 | 11 / 224 | 5.4× | 6.68e-6 | 3.98e-4 ✓ sig. |
| positive regulation of cell differentiation | GO:0045597 | 7 / 83 | 9.3× | 1.06e-5 | 5.68e-4 ✓ sig. |
| male gonad development | GO:0008584 | 8 / 117 | 7.5× | 1.17e-5 | 6.13e-4 ✓ sig. |
| trigeminal nerve structural organization | GO:0021637 | 3 / 6 | 55.0× | 1.45e-5 | 7.26e-4 ✓ sig. |
| gonadotrophin-releasing hormone neuronal migration to the hypothalamus | GO:0021828 | 3 / 6 | 55.0× | 1.45e-5 | 7.26e-4 ✓ sig. |
| nervous system development | GO:0007399 | 18 / 631 | 3.1× | 1.86e-5 | 8.75e-4 ✓ sig. |